98 related articles for article (PubMed ID: 10933813)
1. Solution structure of monomeric peptide YY supports the functional significance of the PP-fold.
Keire DA; Kobayashi M; Solomon TE; Reeve JR
Biochemistry; 2000 Aug; 39(32):9935-42. PubMed ID: 10933813
[TBL] [Abstract][Full Text] [Related]
2. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
3. Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active.
Germain N; Minnion JS; Tan T; Shillito J; Gibbard C; Ghatei M; Bloom S
Peptides; 2013 Jan; 39():6-10. PubMed ID: 23123314
[TBL] [Abstract][Full Text] [Related]
4. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
5. The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR.
Nygaard R; Nielbo S; Schwartz TW; Poulsen FM
Biochemistry; 2006 Jul; 45(27):8350-7. PubMed ID: 16819834
[TBL] [Abstract][Full Text] [Related]
6. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of human neuropeptide Y.
Monks SA; Karagianis G; Howlett GJ; Norton RS
J Biomol NMR; 1996 Dec; 8(4):379-90. PubMed ID: 9008359
[TBL] [Abstract][Full Text] [Related]
8. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity.
Keire DA; Mannon P; Kobayashi M; Walsh JH; Solomon TE; Reeve JR
Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G126-31. PubMed ID: 10898754
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
[TBL] [Abstract][Full Text] [Related]
10. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
[TBL] [Abstract][Full Text] [Related]
11. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
[TBL] [Abstract][Full Text] [Related]
12. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
13. Conformational solution studies of neuropeptide gamma using CD and NMR spectroscopy.
Rodziewicz-Motowidło S; Brzozowskl K; Legowska A; Liwo A; Silbering J; Smoluch M; Rolka K
J Pept Sci; 2002 May; 8(5):211-26. PubMed ID: 12043996
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and function in trifluoroethanol of PP-50, an ATP-binding peptide from F1ATPase.
Chuang WJ; Abeygunawardana C; Gittis AG; Pedersen PL; Mildvan AS
Arch Biochem Biophys; 1995 May; 319(1):110-22. PubMed ID: 7771774
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold.
Bettio A; Dinger MC; Beck-Sickinger AG
Protein Sci; 2002 Jul; 11(7):1834-44. PubMed ID: 12070335
[TBL] [Abstract][Full Text] [Related]
16. Bovine pancreatic polypeptide (bPP) undergoes significant changes in conformation and dynamics upon binding to DPC micelles.
Lerch M; Gafner V; Bader R; Christen B; Folkers G; Zerbe O
J Mol Biol; 2002 Oct; 322(5):1117-33. PubMed ID: 12367532
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of neuropeptide k bound to dodecylphosphocholine micelles.
Dike A; Cowsik SM
Biochemistry; 2006 Mar; 45(9):2994-3004. PubMed ID: 16503654
[TBL] [Abstract][Full Text] [Related]
20. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
